Jesse A. Coker

581 total citations
8 papers, 80 citations indexed

About

Jesse A. Coker is a scholar working on Molecular Biology, Biotechnology and Organic Chemistry. According to data from OpenAlex, Jesse A. Coker has authored 8 papers receiving a total of 80 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 2 papers in Biotechnology and 1 paper in Organic Chemistry. Recurrent topics in Jesse A. Coker's work include Chemical Synthesis and Analysis (2 papers), Transgenic Plants and Applications (2 papers) and Vascular Tumors and Angiosarcomas (1 paper). Jesse A. Coker is often cited by papers focused on Chemical Synthesis and Analysis (2 papers), Transgenic Plants and Applications (2 papers) and Vascular Tumors and Angiosarcomas (1 paper). Jesse A. Coker collaborates with scholars based in United States and United Kingdom. Jesse A. Coker's co-authors include Adam S. Duerfeldt, Eliza A. Ruben, Yugandhar Beesetty, Alex G. Waterson, Jiqing Sai, Edward T. Olejniczak, Allison L. Arnold, Jason Phan, Dhruba Sarkar and Stephen W. Fesik and has published in prestigious journals such as Clinical Cancer Research, Journal of Medicinal Chemistry and Journal of Natural Products.

In The Last Decade

Jesse A. Coker

8 papers receiving 79 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jesse A. Coker United States	5	60	19	12	8	8	8	80
Victor Reys France	5	115 1.9×	12 0.6×	6 0.5×	6 0.8×	5 0.6×	10	171
Kelli A. McCord Canada	5	78 1.3×	12 0.6×	20 1.7×	4 0.5×	7 0.9×	9	126
Aleksandra Usenik Slovenia	5	71 1.2×	10 0.5×	7 0.6×	8 1.0×	5 0.6×	8	128
C. Smee United Kingdom	3	95 1.6×	15 0.8×	14 1.2×	6 0.8×	12 1.5×	3	136
Joshua Hansen United States	6	101 1.7×	9 0.5×	16 1.3×	5 0.6×	2 0.3×	14	151
Bailin Shaw United States	5	126 2.1×	18 0.9×	41 3.4×	12 1.5×	4 0.5×	6	164
Hsuan-Lin Her United States	8	172 2.9×	7 0.4×	12 1.0×	3 0.4×	3 0.4×	12	231
Adélaïde Saint-Léger Spain	8	214 3.6×	12 0.6×	5 0.4×	4 0.5×	5 0.6×	8	234
Andrew Thompson Australia	7	66 1.1×	8 0.4×	13 1.1×	2 0.3×	3 0.4×	11	98
Satenig Guler United States	4	51 0.8×	14 0.7×	49 4.1×	9 1.1×	3 0.4×	4	103

Countries citing papers authored by Jesse A. Coker

Since Specialization

Citations

This map shows the geographic impact of Jesse A. Coker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jesse A. Coker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jesse A. Coker more than expected).

Fields of papers citing papers by Jesse A. Coker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jesse A. Coker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jesse A. Coker. The network helps show where Jesse A. Coker may publish in the future.

Co-authorship network of co-authors of Jesse A. Coker

This figure shows the co-authorship network connecting the top 25 collaborators of Jesse A. Coker. A scholar is included among the top collaborators of Jesse A. Coker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jesse A. Coker. Jesse A. Coker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Pobbati, Ajaybabu V., Todd Romigh, Bin Zhao, et al.. (2024). CDK9 Inhibition by Dinaciclib Is a Therapeutic Vulnerability in Epithelioid Hemangioendothelioma. Clinical Cancer Research. 30(18). 4179–4189. 4 indexed citations

2.

Coker, Jesse A., Christopher M. Goins, Sang Hoon Han, et al.. (2024). Discovery and Characterization of Selective, First-in-Class Inhibitors of Citron Kinase. Journal of Medicinal Chemistry. 67(4). 2631–2666. 3 indexed citations

3.

Coker, Jesse A. & Shaun R. Stauffer. (2024). WD repeat domain 5 (WDR5) inhibitors: a patent review (2016-present). Expert Opinion on Therapeutic Patents. 35(1). 31–45. 1 indexed citations

4.

Coker, Jesse A., V.L. Katis, M. Fairhead, et al.. (2022). FAS2FURIOUS: Moderate-Throughput Secreted Expression of Difficult Recombinant Proteins in Drosophila S2 Cells. Frontiers in Bioengineering and Biotechnology. 10. 871933–871933. 1 indexed citations

5.

Chalk, R., Jesse A. Coker, Shubhashish Mukhopadhyay, et al.. (2021). Identification, mapping and relative quantitation of SARS-CoV-2 Spike glycopeptides by Mass-Retention Time Fingerprinting. Communications Biology. 4(1). 934–934. 5 indexed citations

6.

Sarkar, Dhruba, Edward T. Olejniczak, Jason Phan, et al.. (2020). Discovery of Sulfonamide-Derived Agonists of SOS1-Mediated Nucleotide Exchange on RAS Using Fragment-Based Methods. Journal of Medicinal Chemistry. 63(15). 8325–8337. 21 indexed citations

7.

Coker, Jesse A., et al.. (2017). Consequences of Depsipeptide Substitution on the ClpP Activation Activity of Antibacterial Acyldepsipeptides. ACS Medicinal Chemistry Letters. 8(11). 1171–1176. 13 indexed citations

8.

Coker, Jesse A., et al.. (2016). Sclerotiamide: The First Non-Peptide-Based Natural Product Activator of Bacterial Caseinolytic Protease P. Journal of Natural Products. 79(4). 1193–1197. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact